CLINICAL INVESTIGATION
The ATHENA first-in-human clinical investigation
ATHENA is a first-in-human clinical investigation evaluating the safety and early performance of the patient-specific 3D-Shelf implant in adults with symptomatic hip dysplasia.
First-in-human clinical investigation · Initiated in August 2025
STUDY OVERVIEW
Building clinical evidence for a patient-specific approach
The 3D-Shelf is a patient-specific, extra-articular implant designed for selected adults with symptomatic hip dysplasia. Its design is based on the individual patient's anatomy and is intended to augment acetabular coverage while preserving the native hip joint.
The ATHENA study was initiated at Anna Hospital in Geldrop, the Netherlands. It is evaluating the 3D-Shelf in patients for the first time, with a focus on safety and early clinical performance.
Aim
Safety and early clinical performance
Clinical site
Anna Hospital, Geldrop, the Netherlands
Trial registration
NCT07072832Want to learn more about the ATHENA study?
Detailed information about the study design, eligibility criteria and current study status is available through the official trial registration. Healthcare professionals can also contact the Replasia clinical study team with specific questions.
The 3D-Shelf is an investigational medical device. Its safety and clinical performance are being evaluated in an ongoing clinical investigation. The information on this page does not constitute medical advice.